cyclohexanol has been researched along with Nausea in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.63) | 18.7374 |
1990's | 17 (44.74) | 18.2507 |
2000's | 15 (39.47) | 29.6817 |
2010's | 5 (13.16) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ii, Y; Tourian, K; Wang, Y | 1 |
Feiger, AD; Padmanabhan, SK; Rosas, GR; Tourian, KA | 1 |
Pae, CU | 1 |
Bonelli, RM; Holl, AK; Holl, EM; Painold, A; Wilkinson, L | 1 |
Filatova, EG; Latysheva, NV; Naprienko, MV | 1 |
Astl, D; Ausmanas, MK; Cheng, RF; Gallagher, JC; Seljan, P; Strzinek, RA | 1 |
Canny, LM; Coleman, KA; Meaney, JV; Palmer, TL; Radalj, LM; Xavier, VY | 1 |
DeVane, CL | 1 |
Bothmer, J; Huusom, AK; Montgomery, SA | 1 |
Hindmarch, I; Rigney, U; Stanley, N; Trick, L | 1 |
Gelenberg, AJ; Liebowitz, MR; Munjack, D | 1 |
Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW | 1 |
Bahk, WM; Chae, JH; Jun, TY; Kim, TS; Pae, CU; Rhee, WI; Yoon, SJ | 1 |
Ahmed, S; Baldwin, D; Benattia, I; Davidson, J; Kuper, E; Musgnung, J; Pedersen, R; Stein, DJ | 1 |
Germain, JM; Padmanabhan, SK; Pitrosky, B; Septien-Velez, L; Tourian, KA | 1 |
Aviv, A; Barak, Y; Mazeh, D; Shahal, B; Zemishlani, H | 1 |
Han, C; Joe, SH; Jung, IK; Ko, YH; Lee, BH; Masand, PS; Pae, CU; Patkar, AA | 1 |
Farah, A; Lauer, TE | 1 |
Russell, JL | 1 |
Kirsch, MA; Lannon, RA; Lewis, TB; Louie, AK | 1 |
Haddad, P | 1 |
Nelson, JC | 1 |
Mitchell, S; Tracy, KA; Zajecka, J | 1 |
Thase, ME | 1 |
Albano, D; Amchin, J | 1 |
Entsuah, R; Khan, A; Leventer, SM; Rudolph, RL; Upton, GV | 1 |
Chitra, R; Entsuah, R | 1 |
Derivan, AT; Entsuah, R; Fabre, LF; Feighner, JP; Rickels, K; Rudolph, RL | 1 |
Ansseau, M | 1 |
Macbeth, R; Rajagopalan, M | 1 |
Boyd, IW | 1 |
Joffe, RT; Lee, DK; Marshall, AM | 1 |
McAllister-Williams, RH; Porter, RJ; Young, AH | 1 |
Batchelder, ST; Fedak, MJ; Hellerstein, DJ; Kreditor, D; Little, SA; Rosenthal, J | 1 |
Behnke, K; Mehtonen, OP; Roponen, P; Søgaard, J | 1 |
Jacob, C; Luckhaus, C | 1 |
Chaturachinda, K; O-Prasertsawat, P; Padmasuta, K; Pausawasdi, S; Tangtrakul, S | 1 |
5 review(s) available for cyclohexanol and Nausea
Article | Year |
---|---|
Desvenlafaxine: a new antidepressant or just another one?
Topics: Animals; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Nausea; Randomized Controlled Trials as Topic | 2009 |
Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Delayed-Action Preparations; Drug Tolerance; Half-Life; Humans; Nausea; Paroxetine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2003 |
Newer antidepressants and the discontinuation syndrome.
Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Safety and tolerability of the new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride | 1997 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
23 trial(s) available for cyclohexanol and Nausea
Article | Year |
---|---|
A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Drug Monitoring; Female; Headache; Humans; Incidence; Intention to Treat Analysis; Japan; Male; Middle Aged; Nasopharyngitis; Nausea; Neurotransmitter Uptake Inhibitors; Psychiatric Status Rating Scales | 2013 |
A placebo-controlled study evaluating the efficacy and safety of flexible-dose desvenlafaxine treatment in outpatients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Outpatients; Placebos; Treatment Outcome; Young Adult | 2009 |
Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Huntington Disease; Irritable Mood; Male; Middle Aged; Nausea; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
The effect of dose titration and dose tapering on the tolerability of desvenlafaxine in women with vasomotor symptoms associated with menopause.
Topics: Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Nausea; Neurotransmitter Uptake Inhibitors; Patient Satisfaction; Postmenopause; Vasomotor System | 2012 |
A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Constipation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Primary Health Care; Psychiatric Status Rating Scales; Sweating; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in
Topics: Aged; Cognition; Cyclohexanols; Depressive Disorder; Disorders of Excessive Somnolence; Dizziness; Dothiepin; Double-Blind Method; Drug Administration Schedule; Female; Flicker Fusion; Humans; Male; Narcolepsy; Nausea; Psychometrics; Psychomotor Performance; Time Factors; Venlafaxine Hydrochloride | 2004 |
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Paroxetine; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sweating; Venlafaxine Hydrochloride; Weight Gain | 2006 |
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
Topics: Adult; Ambulatory Care; Cyclohexanols; Delayed-Action Preparations; Dizziness; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Humans; Longitudinal Studies; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Patient Dropouts; Psychiatric Status Rating Scales; Sex Factors; Sweating; Treatment Outcome | 2007 |
A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dizziness; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Nausea; Paroxetine; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia | 2007 |
Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Patient Dropouts; Prospective Studies; Somatoform Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia; Yawning | 2008 |
Relatively low doses of cisapride in the treatment of nausea in patients treated with venlafaxine for treatment-refractory depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Nausea; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists; Venlafaxine Hydrochloride | 1996 |
Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Dizziness; Double-Blind Method; Female; Humans; Male; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
A benefit-risk analysis of once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression.
Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Venlafaxine Hydrochloride | 1997 |
A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.
Topics: Adult; Aged; Ambulatory Care; Anorexia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Placebos; Psychiatric Status Rating Scales; Sleep Wake Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
A large open-label study of venlafaxine in depressed outpatients by community-based physicians.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Community Medicine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Dysthymic Disorder; Family Practice; Female; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia | 1998 |
Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers.
Topics: Adolescent; Adult; Area Under Curve; Clomipramine; Cyclohexanols; Human Growth Hormone; Humans; Male; Nausea; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Tryptophan; Venlafaxine Hydrochloride; Vomiting | 1999 |
Venlafaxine in the treatment of dysthymia: an open-label study.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Dysthymic Disorder; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia | 1999 |
Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Topics: Adult; Aged; Ambulatory Care; Cyclohexanols; Depressive Disorder; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
A comparative study of tramadol and pethidine in laparoscopic interval sterilization.
Topics: Adult; Analgesia; Clinical Trials as Topic; Cyclohexanols; Female; Humans; Meperidine; Nausea; Sterilization, Tubal; Tramadol; Vomiting | 1988 |
10 other study(ies) available for cyclohexanol and Nausea
Article | Year |
---|---|
[New approaches to the treatment of chronic daily headache].
Topics: Adult; Aminopyridines; Analgesics; Attention Deficit Disorder with Hyperactivity; Constipation; Cyclohexanols; Diarrhea; Female; Headache Disorders; Humans; Male; Nausea; Pain Threshold; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An indirect comparison of the efficacy and safety of desvenlafaxine and venlafaxine using placebo as the common comparator.
Topics: Adult; Aged; Antidepressive Agents; Australia; Bayes Theorem; Cyclohexanols; Databases, Factual; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Nausea; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Possible venlafaxine withdrawal syndrome.
Topics: Adult; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Headache; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride | 1996 |
Venlafaxine withdrawal reactions.
Topics: Cyclohexanols; Depressive Disorder; Dizziness; Female; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1996 |
Clinical considerations in managing nausea associated with venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Gastrointestinal Agents; Humans; Nausea; Piperidines; Venlafaxine Hydrochloride | 1997 |
[Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
Topics: Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Drug Administration Schedule; Humans; Hypertension; Nausea; Selective Serotonin Reuptake Inhibitors; Therapeutic Equivalency; Venlafaxine Hydrochloride | 1998 |
Venlafaxine withdrawal syndrome.
Topics: Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1998 |
Venlafaxine withdrawal reactions.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride | 1998 |
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain | 2001 |
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Maprotiline; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2001 |